June 12, 2024
Prof. Dr. Sergi X. Trilla joins Achelous Partners as European Representative

June 12, 2024
Achelous Partners Advises Curia on its announced sale of a US CDMO site to Siegfried

April 22, 2024
Achelous Partners Advises A4P Consulting Ltd on its sale to LabConnect

March 25, 2024
Achelous Partners Advises Six Degrees Medical on its sale to Reverba

December 13, 2023
Achelous Partners Advises Bio X Cell on its sale to Windjammer Capital

November 17, 2023
Achelous Partners Advises Symbio and ProInnovera on their respective sales to Archimed

November 8, 2023
Achelous Partners Advises Pharmalog on its sale to Henko Partners to form Astrum

January 9, 2023
Achelous Partners Advises Alcedis on its sale to Huma

November 9, 2022
Achelous Partners Advises Expression Systems on its sale to ANGUS Chemical Company (a Portfolio Company of Ardian and Golden Gate Capital)

October 3, 2022
Achelous Partners Advises Qfix on its sale to CIVCO Radiotherapy (a Portfolio Company of Blue Wolf Capital Partners)

July 12, 2022
Achelous Partners Advises Cergentis B.V. on its sale to Solvias (a Portfolio Company of JLL Partners and Water Street Healthcare Partners)

July 8, 2022
Achelous Partners Advises proderm GmbH on its sale to SGS

June 7, 2022
Achelous Partners Advises SAI MedPartners on its sale to Northlane Capital

June 7, 2022
Achelous Partners Advises AusDiagnostics on its sale to R-Biopharm AG

November 10, 2021
Achelous Partners Advises Regulatory Compliance Associates on its sale to Sotera Health

August 18, 2021
Achelous Partners Advises DRG International on its sale to BioCheck, Inc.

August 4, 2021
Achelous Partners Advises bioskin GmbH on its sale to Eurofins Scientific (EPA: ERF)

July 23, 2021
Achelous Partners Advises nanoComposix on its sale to Fortis Life Sciences

May 20, 2021
Achelous Partners Advises Clinical Outcomes Solutions, a Global Leader in Clinical Outcomes Assessment Research Services, on its sale to Validant (a Portfolio Company of GHO Capital)

March 2, 2021
Achelous Partners Advises Diamond Pharma Services on its sale to ProPharma Group (a Portfolio Company of Odyssey Investment Partners)

February 23, 2021
Achelous Partners Advises Delphi Genetics on its sale to Catalent

January 4, 2021
Dr. Stephan Wnendt and Dr. Katja Neuer join Achelous Partners as European Representatives

October 26, 2020
Achelous Partners Advises MD Biosciences, Inc. on its sale to MLM Medical Labs (a Portfolio Company of Great Point Partners)

September 21, 2020
Achelous Partners Advises American Laboratory Products Company, Ltd. (ALPCO) on its sale to Ampersand Capital Partners

September 10, 2020
Achelous Partners Advises Maetrics LLC on its sale to Regulatory and Quality Solutions LLC (R&Q, a Portfolio Company of DFW Capital Partners)

August 26, 2020
Achelous Partners Advises CTK Biotech on its sale to SSI Diagnostica (a Portfolio Company of Adelis Equity Partners)

February 26, 2020
Achelous Partners Advises BresMed Health Solutions Ltd. on its sale to Arsenal Capital Partners

January 23, 2020
Achelous Partners Advises Statistics Collaborative, Inc. on its sale to WCG (WIRB-Copernicus Group, a Portfolio Company of Leonard Green & Partners and Arsenal Capital Partners)

December 6, 2019
Achelous Partners Advises MLM Medical Labs on its sale to Great Point Partners

October 28, 2019
Achelous Partners Advises Specialized Medical Services-oncology BV (SMS-oncology) on its sale to Cato Research LLC (a Portfolio Company of JLL Partners and Water Street Healthcare Partners)

July 9, 2019
Achelous Partners Advises EuroLyser GmbH on its sale to ArchiMed

July 8, 2019
Achelous Partners Advises LifeSpan Biosciences, Inc. on its acquisition of Nordic MUbio

March 5, 2019
Achelous Partners Advises Quorum Review IRB on its sale to Advarra (a Portfolio Company of Linden Capital)

January 21, 2019
Achelous Partners CoAdvises ProductLife Group on its sale to 21 Invest

January 4, 2019
Achelous Partners Advises CoreBiome, Inc. on its sale to OraSure Technologies, Inc. (NASDAQ: OSUR)

October 23, 2018
Achelous Partners Advises Pennside Partners Ltd. on its sale to TwoLabs, LLC (a Portfolio Company of Excellere Partners)

October 12, 2018
Artur Aira joins Achelous Partners as its European Representative

September 25, 2018
Achelous Partners Advises NovaTec Immundiagnostica GmbH on its sale to Eurofins Scientific (EPA: ERF)

September 17, 2018
Achelous Partners Advises Thompson Street Capital Partners on its acquisition of LifeSpan Biosciences, Inc.

September 6, 2018
Achelous Partners Advises HyTest Ltd. on its sale to Summa Equity

July 31, 2018
Achelous Partners Advises Gold Standard Diagnostics, Inc. on its sale to Eurofins Scientific (EPA: ERF)

May 23, 2018
Achelous Partners Advises Biovian Oy on its sale to Keensight Capital

January 6, 2018
Achelous Partners Advises LifeCodexx on its sale to Eurofins Scientific (EPA: ERF)

June 2, 2017
Achelous Partners Advises Coté Orphan, LLC on its sale to QuintilesIMS

May 3, 2017
Achelous Partners Advises PharmaCell B.V. on its sale to Lonza Group Ltd.

April 25, 2017
Achelous Partners Advises Emergo Group, Inc. on its sale to UL LLC

April 21, 2017
Achelous Partners Advises Calbiotech, Inc. on its sale to Transasia Bio-Medicals / Erba Mannheim

January 4, 2017
Achelous Partners Advises BioControl Systems Inc. on its sale to Merck KGaA / MilliporeSigma (XETRA: MRK)

August 31, 2016
Achelous Partners Advises SPEware Corporation on its sale to Tecan Group (SIX: TECN)

July 6, 2016
Achelous Partners Advises Sharps Compliance Corp. (Nasdaq: SMED) on its acquisition of Citiwaste, LLC

June 20, 2016
Dr. Jan Boesen discusses M&A strategy and how to best maximize value in a trade sale at BIO-Europe in Stockholm

June 16, 2016
Achelous Partners Advises Argos Soditic and CisBio Bioassays on its sale to Abénex

December 15, 2015
Achelous Partners Advises Sharps Compliance Corp. (Nasdaq: SMED) on its acquisition of Bio-Team Mobile

November 24, 2015
Achelous Partners Advises Abzena plc (AIM: ABZA) on its acquisition of The Chemistry Research Solution LLC (“TCRS”)

September 22, 2015
Achelous Partners Advises Kinesis Pharma BV on its sale to Venn Life Sciences Holding Plc (AIM: VENN)

August 26, 2015
Achelous Partners Advises DIAsource ImmunoAssays on its sale to Anteo Diagnostics (ASX: ADO)

July 20, 2015
Achelous Partners Advises Sharps Compliance Corp. on its acquisition of Alpha Bio/Med Services

May 19, 2015
Dr. Jan Boesen joins Achelous Partners, LLC as its European Representative

March 31, 2015
Achelous Partners Advises Ansell Limited on its acquisition of Microgard Ltd.

August 18, 2014
Achelous Partners advises Valeant Pharmaceuticals (NYSE: VRX) on its acquisition of ophthalmology and orthopedic assets from Croma Pharma GmbH

July 30, 2014
Achelous Partners Advises IBL International Holding BV on its sale to Tecan Group (SIX: TECN)

July 14, 2014
Achelous Partners CoAdvises Phlexglobal Limited on its sale to Bridgepoint Development Capital

June 18, 2014
Achelous Partners Advises Spectris plc (LSE: SXS) on its acquisition of La Corporation Scientifique Claisse

April 23, 2014
Achelous Partners CoAdvises Pharmalink Consulting on its sale to Genpact (NYSE: G)

August 19, 2013
Achelous Partners Advises Kirkegaard & Perry Laboratories (KPL) on its sale to SeraCare Life Sciences

August 9, 2013
Achelous Partners Advises Austofix Group Limited on the sale of its orthopedic reconstruction business to Amplitude, an Apax Partners company

July 23, 2013
Achelous Partners Advises Matrical Bioscience Inc on its sale to Brooks Automation (NASDAQ: BRKS)

July 9, 2013
Achelous Partners Advises The Anson Group LLC on its sale to Navigant Consulting (NYSE: NCI)

July 8, 2013
Achelous Partners Advises Kreatech Diagnostics on its sale to Leica Biosystems/Danaher (NYSE: DHR)

May 22, 2013
Achelous Partners Advises Triangle Biomedical Sciences Inc on its sale to General Data

August 29, 2012
Achelous Partners Advises JSW Life Sciences GmbH on its sale to QPS LLC

March 13, 2012
Achelous Partners Advises Valeant Pharmaceuticals International Inc (NYSE: VRX) on its acquisition of assets from Gerot Lannach

December 23, 2011
Achelous Partners Advises Ansell Ltd (ASX: ANN) on its investment in Lakeland Industries Inc

August 30, 2010
Achelous Partners Advises EnviroLogix Inc on its sale to EnsignBickford Industries Inc

February 1, 2010
Achelous Partners Advises Finnzymes Oy on its sale to Thermo Fisher Scientific Inc (NYSE: TMO)

December 18, 2009
Achelous Partners Advises BTG plc (LSE: BGC) on the licensing of its ReGel® drug delivery system for ophthalmic indications to Allergan Inc

October 23, 2009
Achelous Partners Advises AnaSpec Inc on its sale to Eurogentec SA

August 28, 2009
Achelous Partners Advises BTG plc (LSE: BGC) on the sale of its HySolv™ drug delivery technology to Novartis Pharma AG for up to US$10 million

January 6, 2009
Achelous Partners Advises Labcoat Ltd on its sale to Boston Scientific Corp (NYSE: BSX)

December 8, 2008
Achelous Partners Advises Affymetrix Inc (NASDAQ: AFFX) on its acquisition of Panomics Inc for a total consideration of US$73 million

July 25, 2008
Achelous Partners Advises Biocompatibles (LSE: BII) on its acquisition of BrachySciences Inc and its affiliated companies for a total consideration of up to US$22 million

December 24, 2007
Achelous Partners Advises Sigma Pharmaceuticals Ltd (ASX: SIP) on its acquisition of Orphan Holdings Pty Ltd for a total consideration of A$130 million

October 8, 2007
Achelous Partners Advises Panbio Ltd (ASX: PBO) on its sale to Inverness Medical Innovations, Inc (AMEX: IMA) for a total consideration of A$41 million

May 4, 2007
Achelous Partners Advises Ansell Ltd (ASX: ANN) on its acquisition of Fabrica de Artefatos de Látex Blowtex Ltda of Brazil

December 21, 2006
Achelous Partners Advises GeneMedix plc (LSE: GMX) on its Proposed Restructuring involving a £32.1 million Proposed Strategic Investment by Reliance Life Sciences Pvt Ltd, part of the Reliance Group, India's Largest Private Sector Enterprise

December 21, 2006
Achelous Partners has been Appointed to Act as Financial Advisor to Panbio Limited (ASX: PBO), an International Medical Diagnostics Company

November 27, 2006
Achelous Partners Advises Novozymes (CPSE: NZYM B) on its acquisition of GroPep Ltd (ASX: GRO) for A$100 million

July 7, 2006
Achelous Partners Advises Novozymes (CPSE: NZYM B) on its acquisition of Delta Biotechnology Ltd from the sanofiaventis group

October 19, 2005
Achelous Partners has been Appointed to Act as Financial Advisor to CogState Ltd (ASX: CGS), a Melbourne based Clinical IT Company

October 6, 2005
Achelous Partners has been Appointed to Act as Financial Advisor to GeneMedix plc (LSE: GMX), a UK Biopharmaceutical Company, and its Restructuring Program

January 21, 2005
Achelous Partners Named Frost & Sullivan Pharmaceuticals BuySide M&A Advisor of the Year

October 20, 2004
Achelous Partners Advises Gribbles Group Ltd. (ASX: GGL) on its sale to Healthscope Ltd. Bid